Industrie pharmaceutique : pourquoi une climatisation à tolérance zéro est cruciale pour éviter les rappels de médicaments
Reading time: 4'

Pharmaceutical Industry: Why Zero-Tolerance Air Conditioning Is Crucial to Avoid Drug Recalls

The vital role of rigorous climate control in the pharmaceutical industry: an often-overlooked reality with major consequences

In a sector where precision, safety, and consistent quality are non-negotiable, air conditioning cannot be left to chance. The pharmaceutical industry depends on perfectly controlled environmental conditions—24/7. A slight fluctuation in temperature or humidity can alter a drug’s chemical stability, change its concentration, or compromise its sterility. At AirGreen, we understand that in this field, there’s no room for error.

We were recently commissioned for a critical project: the complete evaluation and optimization of an HVAC system at a pharmaceutical plant in Laval specializing in the production of injectable antibiotics. Here’s a look back at an intervention where the smallest thermal deviation could have cost millions… and lives.

A high-stakes context: when air conditioning becomes a matter of regulatory compliance

The facility was undergoing a compliance audit by Health Canada, with strict requirements for aseptic production zones: thermal tolerance of ±1 °C, relative humidity between 45% and 55%, constant laminar airflow, and controlled positive pressure.

The technical managers reached out to us after noticing micro-variations in temperature within two cleanrooms, putting an active production batch at risk. The danger? A massive drug recall and temporary suspension of the manufacturing line.

Full analysis of the existing HVAC system

Our experts immediately carried out a comprehensive technical assessment, including:

  • Inspection of the Lennox central heat pump, model LGM72H4S-2, 72,000 BTU, installed five years ago.

  • Verification of temperature and humidity sensors in critical zones.

  • Evaluation of the cleanroom air distribution system (HEPA laminar flow).

  • Review of the BMS control software to detect any response delays.

  • Analysis of system behavior during production peaks (nights and weekends).

What we uncovered: small errors with major consequences

  1. Inaccurately calibrated temperature probes, with a 1.4 °C deviation in the filling room.

  2. Slow response time of the regulation system, caused by outdated BMS software.

  3. Slightly clogged HEPA filters, reducing laminar airflow and creating turbulence zones.

  4. Thermal overload during sterilization cycles, poorly compensated by the current heat pump.

  5. Lack of dual redundancy on certain critical components, in violation of internal standards.

Solutions implemented by AirGreen

We operated under a tight 10-day deadline, with night shifts to avoid production downtime. Our solutions included:

  • Full replacement of the sensors with remotely adjustable, calibratable models.

  • Upgrade of the control software to include instant response thresholds.

  • Preventive cleaning and replacement of HEPA filters with digital traceability.

  • Installation of a secondary Lennox M1WD9000 air cooler (9,000 BTU unidirectional cassette) in areas prone to temporary overload.

  • Integration of an intelligent alarm system to automatically alert technicians if deviation exceeds ±0.5 °C.

Results after the upgrade

Two weeks after our intervention, the facility passed its compliance audit with zero remarks, and the managers reported:

  • Constant thermal stability at ±0.3 °C in all critical zones.

  • A 28% reduction in emergency HVAC interventions.

  • Estimated 17% energy savings on the monthly bill thanks to cycle optimization.

Why zero-tolerance air conditioning is vital in the pharmaceutical sector

In such a sensitive environment, air conditioning becomes an indirect medical device. It ensures formulation stability, protects end patients, and upholds regulatory compliance. A poorly reactive or slow HVAC system can result in:

  • Loss of an entire production batch.

  • Sanctions from health authorities.

  • A product recall with legal consequences.

  • Severe damage to brand reputation.

The AirGreen approach for the pharmaceutical industry

At AirGreen, we tailor each solution to the specific production environment. For pharmaceutical plants in Montreal, Laval, Longueuil, South Shore and North Shore, our team offers:

  • High-precision thermal HVAC systems.

  • Rapid and fully documented interventions, including quality validation.

  • Integration of low-GWP refrigerants (such as R-454B) to combine performance and sustainability.

  • Compliance upgrades aligned with GMP, FDA, and Health Canada regulations.

Expertise you can count on

In the pharmaceutical industry, every minute matters. At AirGreen, we know your indoor climate is a vital link in your value chain. With our field experience, certified team, and rapid response, we deliver uncompromising HVAC installations and upgrades.


Do you operate a pharmaceutical plant or controlled-atmosphere lab? Zero-tolerance climate control isn’t a luxury — it’s a necessity. Contact AirGreen for a no-nonsense technical assessment.

Leave a comment